Mesenchymal stem cells(MSCs) have been shown through extensive research to be an abundant source of regenerative properties, and therefore God-sent to the field of regenerative medicine. MSCs are considered a “regenerative biologic agent” rather than a medicinal treatment or “drug,” owing to the unique ability to differentiate into various tissue…
Autoimmunity. 2008 Dec;41(8):611-5. Chronic inflammatory demyelinating polyradiculoneuropathy: a role for haematopoietic stem cell transplantation? Kazmi MA, Mahdi-Rogers M, Sanvito L. Source Department of Haematology, Guy’s and St Thomas’ NHS Foundation Trust, Guy’s Hospital, London, UK. Majid.kazmi@gstt.nhs.uk Abstract Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a clinical syndrome of a chronic progressive…
Nat Rev Neurol. 2011 Aug 16;7(9):507-17. doi: 10.1038/nrneurol.2011.121. Advances in the diagnosis, pathogenesis and treatment of CIDP. Dalakas MC; Medscape. Source Neuroimmunology Unit, Department of Pathophysiology, National University of Athens Medical School, Building 16, Room 39, 75 Mikras Asias Street, Athens 11527, Greece. mdalakas@med.uoa.gr Abstract Chronic inflammatory demyelinating polyneuropathy (CIDP)…